Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126760881 | 12676088 | 1 | I | 20160810 | 20160823 | 20160823 | EXP | FR-CIPLA LTD.-2016FR17694 | CIPLA | VENAT-BOUVET L, SAINT-MARCOUX F, LAGARDE C, PEYRONNET P, LEBRUN-LY V, TUBIANA-MATHIEU N. IRINOTECAN-BASED CHEMOTHERAPY IN A METASTATIC COLORECTAL CANCER PATIENT UNDER HAEMODIALYSIS FOR CHRONIC RENALDYSFUNCTION: TWO CASES CONSIDERED.. ANTICANCER DRUGS. 2007;18 (8):977 TO 980 | 0.00 | Y | 0.00000 | 20160823 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126760881 | 12676088 | 1 | PS | Irinotecan | IRINOTECAN | 1 | 125 MG/M 4 CYCLES | U | U | 77219 | |||||||||
| 126760881 | 12676088 | 2 | SS | Irinotecan | IRINOTECAN | 1 | 180 MG/M | U | U | 77219 | |||||||||
| 126760881 | 12676088 | 3 | SS | Irinotecan | IRINOTECAN | 1 | 120 MG/M | U | U | 77219 | |||||||||
| 126760881 | 12676088 | 4 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | UNK | U | U | 77219 | ||||||||
| 126760881 | 12676088 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK, LV2FU2 REGIMEN | U | U | 0 | ||||||||
| 126760881 | 12676088 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK, FOLFIRI REGIMEN | U | U | 0 | ||||||||
| 126760881 | 12676088 | 7 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | UNK, LV2FU2 REGIMEN | U | U | 0 | ||||||||
| 126760881 | 12676088 | 8 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | UNK, FOLFIRI REGIMEN | U | U | 0 | ||||||||
| 126760881 | 12676088 | 9 | SS | Cetuximab | CETUXIMAB | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126760881 | 12676088 | 1 | Colorectal cancer metastatic |
| 126760881 | 12676088 | 5 | Colorectal cancer metastatic |
| 126760881 | 12676088 | 7 | Colorectal cancer metastatic |
| 126760881 | 12676088 | 9 | Colorectal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126760881 | 12676088 | DE |
| 126760881 | 12676088 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126760881 | 12676088 | Febrile neutropenia | |
| 126760881 | 12676088 | General physical health deterioration | |
| 126760881 | 12676088 | Neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |